Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$433M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$419M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$332M |
| 5 |
RTX Corp
RTX
|
+$322M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AABA
Altaba Inc
AABA
|
+$267M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$181M |
| 3 |
BCR
CR Bard Inc.
BCR
|
+$134M |
| 4 |
IQVIA
IQV
|
+$134M |
| 5 |
LVLT
Level 3 Communications Inc
LVLT
|
+$121M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.07% |
| 2 | Financials | 5.97% |
| 3 | Healthcare | 5.8% |
| 4 | Consumer Discretionary | 5.2% |
| 5 | Communication Services | 4.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BPMC
3426
DELISTED
Blueprint Medicines
BPMC
| $698K | ﹤0.01% |
9,247
+6,331
| +217% | +$445K |
|
3427
CALL
First Trust Health Care AlphaDEX Fund
FXH
$1.08B
| $698K | ﹤0.01% |
+10,000
| New | +$683K |
|
3428
LeMaitre Vascular
LMAT
$1.86B
| $698K | ﹤0.01% |
21,915
+6,267
| +40% | +$215K |
|
3429
CALL
Under Armour Class C
UA
$2.53B
| $697K | ﹤0.01% |
52,300
-40,900
| -44% | -$536K |
|
3430
Vistra
VST
$47.4B
| $697K | ﹤0.01% |
38,029
-713,148
| -95% | -$13.4M |
|
3431
Zillow
ZG
$7.63B
| $697K | ﹤0.01% |
17,120
+12,588
| +278% | +$517K |
|
3432
PUT
Celanese
CE
$4.82B
| $696K | ﹤0.01% |
6,500
+5,800
| +829% | +$616K |
|
3433
iShares S&P India Nifty 50 Index Fund
INDY
$569M
| $696K | ﹤0.01% |
18,750
| – | – |
|
3434
Sasol
SSL
$7.1B
| $696K | ﹤0.01% |
20,316
+3,033
| +18% | +$91.8K |
|
3435
CALL
Stanley Black & Decker
SWK
$15.7B
| $696K | ﹤0.01% |
4,100
+400
| +11% | +$65.5K |
|
|
TOUR
3436
Tuniu
TOUR
$55.6M
| $696K | ﹤0.01% |
9,070
+4,690
| +107% | +$367K |
|
|
CCF
3437
DELISTED
Chase Corporation
CCF
| $695K | ﹤0.01% |
5,762
+966
| +20% | +$115K |
|
3438
CALL
First Majestic Silver
AG
$9.07B
| $694K | ﹤0.01% |
103,000
-30,400
| -23% | -$210K |
|
|
RRD
3439
DELISTED
RR Donnelley & Sons Co.
RRD
| $694K | ﹤0.01% |
74,648
+64,205
| +615% | +$586K |
|
|
BGC
3440
CALL
DELISTED
General Cable Corporation
BGC
| $693K | ﹤0.01% |
23,400
-70,600
| -75% | -$1.67M |
|
3441
Heritage Insurance Holdings
HRTG
$991M
| $691K | ﹤0.01% |
38,292
+25,588
| +201% | +$425K |
|
3442
LXP Industrial Trust
LXP
$3.57B
| $691K | ﹤0.01% |
14,323
+7,311
| +104% | +$376K |
|
3443
Old National Bancorp
ONB
$10.2B
| $687K | ﹤0.01% |
39,392
+15,454
| +65% | +$278K |
|
3444
PUT
Shopify
SHOP
$195B
| $687K | ﹤0.01% |
68,000
-27,000
| -28% | -$277K |
|
|
ZEN
3445
DELISTED
ZENDESK INC
ZEN
| $687K | ﹤0.01% |
20,329
+15,636
| +333% | +$512K |
|
|
ACH
3446
Accendra Health
ACH
$214M
| $686K | ﹤0.01% |
36,367
+2,268
| +7% | +$50.3K |
|
3447
Valley National Bancorp
VLY
$8.04B
| $686K | ﹤0.01% |
61,144
+25,761
| +73% | +$299K |
|
3448
CALL
Adient
ADNT
$1.5B
| $685K | ﹤0.01% |
8,710
-8,000
| -48% | -$645K |
|
3449
CALL
Chord Energy
CHRD
$7.39B
| $684K | ﹤0.01% |
81,300
+20,800
| +34% | +$192K |
|
|
RVNC
3450
DELISTED
Revance Therapeutics, Inc.
RVNC
| $684K | ﹤0.01% |
19,136
+7,417
| +63% | +$213K |
|
Similar funds
Barclays's Q4 2017 Portfolio in Review
As of Q4 2017, Barclays held 7,416 positions worth $122B, up 26% from $97.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays deployed $19.9B of net new capital in Q4 2017, opening 435 new positions and adding to 3,853 existing holdings. Its largest new stake was iShares US Home Construction ETF: 198,606 shares worth $8.68M.
By sector, the portfolio is most concentrated in Technology at 7.1% of assets, up from 6.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Altaba Inc, an estimated $267M trimmed.
- Barclays's largest Q4 2017 buy was iShares US Home Construction ETF: 198,606 shares worth $8.68M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.24B increase.
- Barclays's biggest Q4 2017 reduction was Altaba Inc, cutting an estimated $267M.
- Barclays fully exited CR Bard Inc. in Q4 2017, selling an estimated $134M.
- Barclays's ten largest holdings make up 24% of its $122B portfolio in Q4 2017.
- Barclays opened 435 new positions and closed 356 in Q4 2017.
- Barclays's portfolio value rose 26% quarter-over-quarter to $122B.
Based on Barclays's 13F filing for Q4 2017, filed 14 Feb 2018.